Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia.
Alterity Therapeutics stock last closed at $5.10, up 1.39% from the previous day, and has increased 277.78% in one year. It has overperformed other stocks in the Biotechnology industry by 3.4 percentage points. Alterity Therapeutics stock is currently +409.49% from its 52-week low of $1.00, and -27.14% from its 52-week high of $7.00.
At the moment, there are 5.32B ATHE shares outstanding. The market cap of ATHE is $54.27M. In the last 24 hours, 8000 ATHE shares were traded.
You will need an online brokerage account in order to access the NASDAQ market and buy ATHE stock.
Based on our analysis, eToro is the best stock brokerage. Here's why:
Get $10 towards your purchase of shares by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've chosen the right brokerage, it's time to fill out some personal details so you can invest in ATHE today.
Now that you've filled out your info on a good stock buying app, your next step is to transfer the money for your investment:
Check out this video walkthrough if you need help transferring funds into your new investment account.
Once you have chosen the best place to buy Alterity Therapeutics stock, it's crucial to evaluate their stock prior to buying, so you truly understand the risk as well as the opportunity.
WallStreetZen was built to help part-time investors do more in-depth fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on ATHE's stock page.
You can use many financial metrics, analyses, models, and charts to gauge ATHE's intrinsic value.
Using relative valuations measures:
You can access more valuation analysis on ATHE's stock here.
Last year, ATHE revenue was $2.34M. Over the past 5 year, ATHE's revenue has grown by -5.46% per year. This was slower than the Biotechnology industry average of 64.56%.
Dive into ATHE's earnings and revenue performance here.
In the last year, insiders at ATHE have not bought or sold any shares.
Get more info about who owns ATHE shares here.
No, Alterity Therapeutics doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
You have two primary types of orders:
Click the Open button and eToro will execute your order.
If you require additional help buying stocks on eToro, click the how to video below:
Now that you own some ATHE shares, you'll want to keep up with your investment.
Start a watchlist to get alerted to the latest events about your ATHE stock.
To reiterate, here are the 6 steps you need to take to buy Alterity Therapeutics stock right now:
If you require a brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you would like to watch your investment in Alterity Therapeutics, create your watchlist below.